SCHEMBL30516651

SCHEMBL30516651

O=C(NC1CCC12CCC2)c1ccsc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 1/20 0.50
▸ HPGD P15428 1/20 0.41
▸ CES2 O00748 1/20 0.40
▸ CES1 P23141 1/20 0.40
▸ LCK P06239 1/20 0.39
▸ FYN P06241 1/20 0.39
▸ DAO P14920 1/20 0.39
▸ CTSS P25774 5/20 0.37
▸ KCNK3 O14649 1/20 0.37
▸ KCNK9 Q9NPC2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ CTSL P07711 2/20 0.36
▸ TRPA1 O75762 1/20 0.35
▸ MAPK10 P53779 1/20 0.35
▸ PTGDR Q13258 2/20 0.34
▸ ACKR3 P25106 1/20 0.34
▸ TBXA2R P21731 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30516654 0.77 HDAC1 (0.43) HDAC1HPGDCES2CES1LCK
SCHEMBL12181487 0.75 HDAC1 (0.55) HDAC1HPGDCES2CES1NPC1
SCHEMBL12181152 0.75 HDAC1 (0.55) HDAC1HPGDCES2CES1LCK
SCHEMBL30516670 0.75 NPC1 (0.49) HPGDDAOCTSSNPC1RAB9A
SCHEMBL15296751 0.75 HDAC1 (0.58) HDAC1HPGDCES2CES1LCK
SCHEMBL30516660 0.74 TSHR (0.60) HDAC1HPGDNPC1RAB9A
SCHEMBL15296752 0.74 RAB9A (0.57) HDAC1HPGDNPC1RAB9AACKR3
SCHEMBL30516667 0.74 HDAC1 (0.40) HDAC1HPGDCES2CES1LCK
Hydrochloric Acid SCHEMBL27721996 0.73 HDAC1 (0.56) HDAC1HPGDCES2CES1LCK
SCHEMBL30516645 0.72 NAMPT (0.39) HPGDNPC1RAB9APTGDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116529238-A Novel prostaglandin E 2 Compounds with receptor inhibiting activity and uses thereof 治纳辅医药科技有限公司 2023-08-01 — — CN disclosed
Send feedback